Cancers投稿须知_审稿周期

期刊简介

《Cancers》是由MDPI (Basel, Switzerland)出版社于2009年创办的英文国际期刊（ISSN: 2072-6694，E-ISSN: 2072-6694），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为Medicine-Oncology。作为SCIE收录期刊（JCR分区 Q1，中科院 2区），本刊采用OA开放获取模式（OA占比1%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比65.51%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在5643篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancers审稿周期约为约18.07天 11 Weeks 。该刊近年被列入国际预警名单，年发文量约5643篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
是是否预警
SCIE 期刊收录
5643 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 2区	ONCOLOGY 肿瘤学 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
是	否	医学 2区	ONCOLOGY 肿瘤学 2区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	78 / 322	75.9%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	91 / 322	71.89%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：8

SJR：1.391

SNIP：1.03

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	81 / 404	79%
大类：Medicine 小类：Cancer Research	Q2	72 / 230	68%

期刊发文

Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis
Author: Zou, Huimin; Lei, Qing; Yan, Xin; Lai, Yunfeng; Ung, Carolina Oi Lam; Hu, Hao

Journal: CANCERS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/cancers15010260
Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment
Author: Zhuang, Yanyan; Lan, Sihua; Zhong, Wa; Huang, Fengting; Peng, Juanfei; Zhang, Shineng

Journal: CANCERS. 2023; Vol. 15, Issue 2, pp. -. DOI: 10.3390/cancers15020474
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance
Author: Zhao, Ziyi; Mei, Yong; Wang, Ziyang; He, Weiling

Journal: CANCERS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/cancers15010062
Radiotherapy Fraction in Limited-Stage Small Cell Lung Cancer in the Modern Era: A Systematic Review and Meta-Analysis of 8006 Reconstructed Individual Patient Data
Author: Zhao, Jingjing; Wu, Linfang; Hu, Chen; Bi, Nan; Wang, Luhua

Journal: CANCERS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/cancers15010277
Research Progress and Direction of Novel Organelle-Migrasomes
Author: Zhang, Yu; Zhang, Minghui; Xie, Zhuoyi; Ding, Yubo; Huang, Jialu; Yao, Jingwei; Lv, Yufan; Zuo, Jianhong

Journal: CANCERS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/cancers15010134
Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer
Author: Zhang, Wentao; Yang, Fuhan; Zheng, Zongtai; Li, Cheng; Mao, Shiyu; Wu, Yuan; Wang, Ruiliang; Zhang, Junfeng; Zhang, Yue; Wang, Hong; Li, Wei; Huang, Jianhua; Yao, Xudong

Journal: CANCERS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/cancers15010131
Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential
Author: Zhang, Wenqin; Yan, Yuanliang; Peng, Jinwu; Thakur, Abhimanyu; Bai, Ning; Yang, Keda; Xu, Zhijie

Journal: CANCERS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/cancers15010286
Predicting Tumor Perineural Invasion Status in High-Grade Prostate Cancer Based on a Clinical-Radiomics Model Incorporating T2-Weighted and Diffusion-Weighted Magnetic Resonance Images
Author: Zhang, Wei; Zhang, Weiting; Li, Xiang; Cao, Xiaoming; Yang, Guoqiang; Zhang, Hui

Journal: CANCERS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/cancers15010086

Cancers

癌症

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询